1. Home
  2. HUIZ vs RGNT Comparison

HUIZ vs RGNT Comparison

Compare HUIZ & RGNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Huize Holding Limited

HUIZ

Huize Holding Limited

SELL

Current Price

$2.10

Market Cap

12.6M

Sector

Finance

ML Signal

SELL

Logo Regentis Biomaterials Ltd. Ordinary Shares

RGNT

Regentis Biomaterials Ltd. Ordinary Shares

HOLD

Current Price

$0.72

Market Cap

14.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HUIZ
RGNT
Founded
2006
2004
Country
China
Israel
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.6M
14.3M
IPO Year
2019
2022

Fundamental Metrics

Financial Performance
Metric
HUIZ
RGNT
Price
$2.10
$0.72
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
25.4K
★ 43.5K
Earning Date
08-20-2026
09-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$6.27
N/A
Revenue Next Year
$11.13
N/A
P/E Ratio
$7.81
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.04
$0.81
52 Week High
$3.83
$15.50

Technical Indicators

Market Signals
Indicator
HUIZ
RGNT
Relative Strength Index (RSI) 49.77 21.62
Support Level $1.52 N/A
Resistance Level $2.16 $2.52
Average True Range (ATR) 0.17 0.15
MACD -0.04 -0.03
Stochastic Oscillator 27.66 3.85

Price Performance

Historical Comparison
HUIZ
RGNT

About HUIZ Huize Holding Limited

Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies that cooperate with the company, which the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers a digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners. Geographically, the company is concentrated in PRC Mainland, Hong Kong and others segments.

About RGNT Regentis Biomaterials Ltd. Ordinary Shares

Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.

Share on Social Networks: